Tikacad 90 Tablet
Marketer
Cadila Pharmaceuticals Ltd
Salt Composition
Ticagrelor (90mg)
Overview Tikacad 90 Tablet
CardioGuard 90mg tablets are antiplatelet agents, working by inhibiting blood clot formation within blood vessels. This action helps prevent cardiac events like heart attacks and strokes in patients with heart conditions. CardioGuard 90mg is also indicated for post-heart attack patients, those experiencing unstable angina, and individuals who have undergone cardiac stenting. Its use reduces the risk of further heart attacks, strokes, and stent thrombosis. Concurrent use with aspirin, another antiplatelet drug, is typically prescribed. CardioGuard 90mg can be administered with or without food, consistently at the same time daily for optimal efficacy. Discontinuation may increase the risk of recurrent cardiac events. The most frequent adverse effect is increased bleeding tendency, potentially prolonging bleeding time from injuries. While usually mild and self-limiting, persistent or worsening bleeding should be reported. Some patients may experience mild, transient shortness of breath, generally resolving with continued therapy. Report any persistent or worsening respiratory symptoms. CardioGuard 90mg is contraindicated in patients with active bleeding (e.g., ulcers, intracranial hemorrhage) or liver disease. Prior to commencing treatment, disclose any relevant medical history to your physician.
Uses of Tikacad 90 Tablet
Reducing the risk of cardiovascular events
Major Benefits of Tikacad 90 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Tikacad 90 Tablet whole; avoid chewing, crushing, or breaking it. Consumption may coincide with meals or not, but consistent timing is recommended.
Common Side effects of Tikacad 90 Tablet:
- Bleeding
- Breathlessness
How to use Tikacad 90 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Tikacad 90 Tablet whole; avoid chewing, crushing, or breaking it. This medication can be taken with or without food, but consistency in timing is recommended.
How Tikacad 90 Tablet works:
Ticagrelor 90mg tablets are a medication that inhibits platelet aggregation, reducing the risk of dangerous blood clots and subsequently lowering the likelihood of stroke or myocardial infarction.
SAFETY ADVICE
AlcoholCAUTION
Use of alcohol with Tikacad 90 Tablet requires careful consideration. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Tikacad 90 Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any possible risks prior to prescribing. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
Data on Tikacad 90 Tablet use while breastfeeding is lacking. Seek medical advice from your physician.
DrivingSAFE
Driving ability is typically unaffected by Tikacad 90 Tablet.
KidneySAFE IF PRESCRIBED
Tikacad 90 Tablet is considered safe for individuals with kidney disease, requiring no dosage modification. Data regarding its use in patients undergoing renal dialysis is currently limited.
LiverCAUTION
Patients with liver impairment should use Tikacad 90 Tablet cautiously, potentially requiring dosage modification. A physician's consultation is advised. Tikacad 90 Tablet is contraindicated in patients exhibiting severe hepatic dysfunction.
What if you forget to take Tikacad 90 Tablet :
Should you forget a Tikacad 90 Tablet dose, take it immediately. If your next dose is imminent, however, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Tikacad 90 Tablet
| Label | Value |
|---|---|
| Chemical Category | Triazolopyrimidine derivatives |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Actions | ADP receptor antagonists (P2Y12 inhibitors) |





